Uncategorized - March 21, 2022
Study reveals new genetic risk factors for migraine
The largest genetic study of migraine to date reveals new genetic risk factors. In the largest genome study of migraine yet, researchers have more than tripled the number of known genetic risk factors for migraine. Among the identified 123 genetic regions are two that contain target genes of recently developed migraine-specific drugs. The study involved […]
Uncategorized - March 16, 2022
New platform for automated cell type identification
Researchers at FIMM have developed a computational approach that can automatically identify various cell types based on single-cell RNA-sequencing data. The method has a huge potential for unbiased profiling of mixtures of cells, both for large-scale projects and samples derived from a single patient, states the researchers. It is not yet known how many different […]
COVID-19 - July 12, 2021
Researchers have identified genetic risk factors for severe COVID-19
A comprehensive summary, based on the analyses of nearly 50,000 patients and published in Nature, reveals 13 genetic regions that are strongly associated with infection or severe COVID-19. Why do some people get severely ill from COVID-19? In addition to risk factors such as age and diabetes, some of this is attributable to our varying […]
In a new job - August 25, 2020
She is the new Head of FIMM Metabolomics Unit
Anni Nieminen-Viheriäranta started as the new Head of Metabolomics Unit of the FIMM Technology Centre in May. Her background is in cancer cell biology and metabolic reprogramming. She finished her PhD on cancer and apoptosis in the Faculty of Medicine, University of Helsinki, in 2014. After that, she has worked as an Academy of Finland […]
COVID-19 - June 9, 2020
Online event: COVID-19 research in Helsinki
During an online event, June 11th, organized by the Helsinki Institute of Life Science four researchers will speak about their current research and discuss how the COVID-19 crisis could be solved. Are certain people more susceptible than others to COVID-19? How does the SARS-CoV-2 virus spread on surfaces and in the air? Can we develop […]
Uncategorized - April 16, 2020
Disease prevention and cancer screening would benefit from genomic risk assessment
A new Finnish study has demonstrated the benefits of large-scale genomic information in estimating the risk of onset for cardiac diseases, diabetes and common cancers. The findings, based on the FinnGen research dataset encompassing more than 135,000 Finns, show that new tools based on genomic data are helpful in identifying high-risk individuals not identified by […]
